Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 293-261-7 | CAS number: 91052-99-2 A complex combination of hydrocarbons obtained from distillation of the butadiene-free C4 fraction of a naphtha steam-cracking process. It consists predominantly of branched olefinic hydrocarbons having carbon numbers of C8, C12, C16 and C20 and boiling in the range of approximately 105°C to 120°C (221°F to 248°F).
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP compliant, guideline study, available as unpublished report, no restrictions, fully adequate for assessment
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 006
- Report date:
- 2006
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5395 (In Vivo Mammalian Cytogenetics Tests: Erythrocyte Micronucleus Assay)
- Deviations:
- yes
- Remarks:
- exposed by inhalation (generally in compliance with EPA OPPTS 870.1300
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- Diisobutylene
- IUPAC Name:
- Diisobutylene
- Details on test material:
- - Name of test material (as cited in study report): Diisobutylene
- Sample ID Number ID# GCRD10401R
- Physical state: Clear light brown liquid
- Chemical composition of sample of diisobutylene: approximately 70% 2,4,4-trimethylpentene (detailed chemical composition information provided in Table 1).
- Storage condition of test material: Refrigerated
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Crl:CD®(SD)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories, Raleigh, North Carolina, USA
- Age at study initiation: approximately 8 weeks
- Weight at study initiation: 233 g to 271 g for males and 174 g to 206 g for females
- Assigned to test groups randomly: yes
- Fasting period before study: No
- Housing: Individual suspended wire-mesh cages. individual suspended wire-mesh cages. On the day of exposure, the animals were placed in wire mesh batteries containing 24 separate cages.
- Diet: Certified Rodent LabDiet® 5002 (PMI Nutrition International, LLC) ad libitum (except during exposure).
- Water: Municipal water ad libitum (except during exposure).
- Acclimation period: Minimum of 7 days
ENVIRONMENTAL CONDITIONS
- Temperature: 21.3ºC to 21.4ºC
- Humidity: 36.6% to 39.2%
- Air changes (per hr): Not reported
- Photoperiod: (12 hrs dark / 12 hrs light)
IN-LIFE DATES: From: 13 December 2005 To: 15 December 2005
Administration / exposure
- Route of administration:
- inhalation: vapour
- Vehicle:
- Vehicle(s)/solvent(s) used: air
- Details on exposure:
- TYPE OF INHALATION EXPOSURE: whole body
GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
Exposure apparatus: 1000 L whole-body inhalation chambers operated at a minimum of 10 air changes per hour. Exposure atmosphere conditions were recorded approximately every 30 minutes during the exposure. Oxygen content was measured pre-exposure. The time required to attain 99% of the equilibrium concentration (or clearance time for the concentration to decrease from the equilibrium concentration) was calculated.
A vapour atmosphere of the test article was generated and piped to the inlet of the whole body chamber where it was mixed with the chamber supply air. Exhaust atmosphere passed through an in-house exhaust system.
TEST ATMOSPHERE
- Brief description of analytical method used: Two primary compounds of the test article, DIB-1 (2,4,4-trimethyl-1-pentene) and DIB-2 (2,4,4-trimethyl-2-pentene), were analyzed independently with each sample obtained by gas chromatography.
- Samples taken from breathing zone: yes - Duration of treatment / exposure:
- 4h
- Frequency of treatment:
- single exposure
- Post exposure period:
- 24 / 48 hours
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
0, 1048, 2159, 4158 ppm diisobutylene
Basis:
nominal conc.
- Remarks:
- Doses / Concentrations:
0, 995, 2035, 4015 ppm diisobutylene
Basis:
analytical conc.
- Remarks:
- Doses / Concentrations:
0, 579, 1184, 2335 ppm DIB-1
Basis:
analytical conc.
- Remarks:
- Doses / Concentrations:
0, 181, 371, 733 ppm DIB-2
Basis:
analytical conc.
- No. of animals per sex per dose:
- 10/sex/group for sham controls and 4015 ppm, 5/sex/group for 995, 2035 ppm and for positive controls
- Control animals:
- yes, sham-exposed
- Positive control(s):
- cyclophosphamide
- Route of administration: intraperitoneal injection
- Doses / concentrations: 10mL/kg (analysed)
Examinations
- Tissues and cell types examined:
- erythrocytes in rat bone marrow
- Details of tissue and slide preparation:
- Bone marrow smears were prepared from the femurs of each animal, fixed in methanol and air dried.
- Evaluation criteria:
- 2000 polychromatic erythrocytes (PCEs), were scored per animal for the presence of micronuclei (micronucleated PCEs, MPCEs). The number of micronucleated normocytes in the field of 2000 polychromatic erythrocytes were enumerated, but not used to evaluate the response of the test article. The proportion of polychromatic erythrocytes to total erythrocytes was recorded per 1000 erythrocytes in test article-treated animals should not be less than 20% of the control value. The mean incidence of micronucleated polychromatic erythrocytes must not exceed 5/1000 polychromatic erythrocytes (0.5%) in the negative control. The incidence of micronucleated polychromatic erythrocytes per 2000 polychromatic erythrocytes for each animal and per 10,000 PCEs per each treatment group was determined.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- - Mortality: No mortalities
- Clinical Signs: At post-exposure observation period - red material around the nose in the 0 ppm, 4015 ppm and positive control groups and yellow material on the urogenital and ventral abdominal area and clear material on the upper left hind limb in the 4015 ppm group.
- Bodyweight: All animals lost weight during the post-exposure observation period. By the end of the post-exposure observation period, animals at 0, 995, 2035 and 4015 ppm groups lost up to 6, 3, 8 and 17 grams, respectively, below their initial body weight. Animals in the positive control group lost (up to 18 grams) weight similarly to the 4015 ppm group.
- MPCEs: The number of micronucleated polychromatic erythrocytes in the bone marrow for the 995, 2035 and 4015 ppm groups was not significantly increased relative to the negative control group at either the 24 hour or 48 hour bone marrow collections.
Any other information on results incl. tables
Summary of acute study test atmosphere characteristics of diisobutylene
Test atmosphere characteristics |
|||||
Target concentration (ppm) |
0 (control) |
1000 |
2000 |
4000 |
40 mL/kg CP |
Nominal concentration (ppm) |
0 |
1048 |
2159 |
4158 |
- |
Test article used (g) |
0 |
226 |
477 |
941 |
- |
Total volume chamber air (L) |
47040 |
48240 |
49440 |
50640 |
- |
Analytical concentration (mean) |
0 |
995 |
2035 |
4015 |
10 mL/kg |
Mean concentration of DIB-1(ppm) |
0 |
579 |
1184 |
2335 |
- |
Mean concentration of DIB-2 (ppm) |
0 |
181 |
371 |
733 |
756 ppm (n=5) |
Flowrate (mL/min) |
N/A |
12 |
29 |
56 |
- |
Temperature |
21°C ± 0 (n=8) |
24°C ± 0.7 (n=8) |
22°C ± 0.5 (n=8) |
25°C ± 0.7 (n=8) |
- |
Humidity |
46% ± 0.9 (n=8) |
30% ± 1.2 (n=8) |
34% ± 1.2 (n=8) |
35% ± 0.7 (n=8) |
- |
CP = cyclophosphamide monohydrate
- not reportedApplicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
Diisobutylene at concentrations of 995, 2035 and 4015 ppm was negative in the mammalian erythrocyte micronucleus assay when male and female
albino rats were exposed to a single, 4-hour, whole-body exposure. - Executive summary:
Based on the results of this study, Diisobutylene at concentrations of 995, 2035 and 4015 ppm did not induce a statistically significant increase in the incidence of micronucleated polychromatic erythocytes in the bone marrow when male and female albino rats were exposed to test article as a single, 4-hour, whole-body exposure.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.